NCT00700336 2021-07-20Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)CanBas Co. Ltd.Phase 1/2 Completed69 enrolled 9 charts
NCT03113188 2021-03-10CBP501, Cisplatin and Nivolumab in Advanced Refractory TumorsCanBas Co. Ltd.Phase 1 Completed47 enrolled